RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Increased Effect-Site Concentration of Propofol Reduces EC50 of Remifentanil for Successful Intubation Using the Shikani Optical Stylet without Neuromuscular Blockade

      한글로보기

      https://www.riss.kr/link?id=A106987381

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objective: For short-duration surgery, propofol and remifentanil are the drugs of choice for intubation without neuromuscular
      blockade. The Shikani Optical Stylet (SOS) is a novel semi-rigid type fiberoptic laryngoscope. In this study, we determined the clinically
      required effect-site concentration of remifentanil for intubation using SOS without neuromuscular blockade depending on
      propofol effect-site concentration.
      Methods: We enrolled patients scheduled for elective surgery with general anesthesia, and assigned them into two groups by a
      randomized, double-blind method: concentration of propofol 3.5 μg/mL (group PRO 3.5) and 7.0 μg/mL (group PRO 7.0). Anesthesia
      was conducted with target-controlled infusion in predetermined target effect-site concentrations of propofol. The concentration
      of remifentanil for successful intubation using SOS in 50% of patients (EC50) was determined using a modified Dixon’s up-anddown
      method.
      Results: The mean±standard deviation EC50 of remifentanil was 5.07±0.40 ng/mL in group PRO 3.5 and 1.79±0.44 ng/mL in group
      PRO 7.0. From probit analysis, EC50 and EC95 of remifentanil in group PRO 3.5 were 4.85 ng/mL (95% confidence interval [CI], 4.44–
      5.16 ng/mL) and 5.42 ng/mL (95% CI, 5.13–7.47 ng/mL) respectively, and EC50 and EC95 of remifentanil in group PRO 7.0 were 1.68
      ng/mL (95% CI, 1.22–2.01 ng/mL) and 2.29 ng/mL (95% CI, 1.98–4.05 ng/mL), respectively.
      Conclusion: Increased concentration of propofol reduced EC50 of remifentanil for successful intubation using SOS without neuromuscular
      blockade.
      번역하기

      Objective: For short-duration surgery, propofol and remifentanil are the drugs of choice for intubation without neuromuscular blockade. The Shikani Optical Stylet (SOS) is a novel semi-rigid type fiberoptic laryngoscope. In this study, we determined t...

      Objective: For short-duration surgery, propofol and remifentanil are the drugs of choice for intubation without neuromuscular
      blockade. The Shikani Optical Stylet (SOS) is a novel semi-rigid type fiberoptic laryngoscope. In this study, we determined the clinically
      required effect-site concentration of remifentanil for intubation using SOS without neuromuscular blockade depending on
      propofol effect-site concentration.
      Methods: We enrolled patients scheduled for elective surgery with general anesthesia, and assigned them into two groups by a
      randomized, double-blind method: concentration of propofol 3.5 μg/mL (group PRO 3.5) and 7.0 μg/mL (group PRO 7.0). Anesthesia
      was conducted with target-controlled infusion in predetermined target effect-site concentrations of propofol. The concentration
      of remifentanil for successful intubation using SOS in 50% of patients (EC50) was determined using a modified Dixon’s up-anddown
      method.
      Results: The mean±standard deviation EC50 of remifentanil was 5.07±0.40 ng/mL in group PRO 3.5 and 1.79±0.44 ng/mL in group
      PRO 7.0. From probit analysis, EC50 and EC95 of remifentanil in group PRO 3.5 were 4.85 ng/mL (95% confidence interval [CI], 4.44–
      5.16 ng/mL) and 5.42 ng/mL (95% CI, 5.13–7.47 ng/mL) respectively, and EC50 and EC95 of remifentanil in group PRO 7.0 were 1.68
      ng/mL (95% CI, 1.22–2.01 ng/mL) and 2.29 ng/mL (95% CI, 1.98–4.05 ng/mL), respectively.
      Conclusion: Increased concentration of propofol reduced EC50 of remifentanil for successful intubation using SOS without neuromuscular
      blockade.

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼